Analysis Linking UCLA PCI With Expanded Prostate Cancer Index Composite: An Evaluation of Health Related Quality of Life in Japanese Men With Localized Prostate Cancer-Reference-Cited by-同舟云学术

Analysis Linking UCLA PCI With Expanded Prostate Cancer Index Composite: An Evaluation of Health Related Quality of Life in Japanese Men With Localized Prostate Cancer

Published:2007-08 Issue:2 Volume:178 Page:473-477
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Namiki Shunichi¹,Takegami Misa,Kakehi Yoshiyuki²,Suzukamo Yoshimi³,Fukuhara Shunichi⁴,Arai Yoichi¹

Affiliation:

1. Department of Urology, Tohoku University Graduate School of Medicine, Sendai

2. Department of Urology, Kagawa University Faculty of Medicine, Kagawa, Japan

3. Physical Medicine and Rehabilitation, Tohoku University Graduate School of Medicine, Sendai

4. Department of Epidemiology and Healthcare Research, Kyoto University Graduate School of Medicine and Public Health, Kyoto

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference19 articles.

1. Life after radical prostatectomy: a longitudinal study;Litwin;J Urol,2001

2. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study;Potosky;J Natl Cancer Inst,2000

3. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology;Aaronson;J Natl Cancer Inst,1993

4. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument;Esper;Urology,1997

5. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure;Litwin;Med Care,1998

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Converting between the International Prostate Symptom Score (IPSS) and the Expanded Prostate Cancer Index Composite (EPIC) urinary subscales: modeling and external validation;BMC Urology;2024-02-03

2. Converting between the International Prostate Symptom Score (IPSS) and the Expanded Prostate Cancer Index Composite (EPIC) Urinary Subscales: Modeling and External Validation;2023-09-22

3. Translating Attention-Deficit/Hyperactivity Disorder Rating Scale-5 and Weiss Functional Impairment Rating Scale-Parent Effectiveness Scores into Clinical Global Impressions Clinical Significance Levels in Four Randomized Clinical Trials of SPN-812 (Viloxazine Extended-Release) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder;Journal of Child and Adolescent Psychopharmacology;2021-04-01

4. Importance of patient-reported outcomes and health-related quality of life when considering prostate cancer treatment;Hong Kong Medical Journal;2020-04-17

5. Patient Reported Comparative Effectiveness of Contemporary Intensity Modulated Radiation Therapy Versus External Beam Radiation Therapy of the Mid 1990s for Localized Prostate Cancer;Urology Practice;2018-11